Ikarian Capital, LLC Ascendis Pharma A/S Call Options Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	SELL	$112.67 - $176.92 $22,534 - $35,384	-200 Reduced 2.33%	8,400 $1.34 Million
Q2 2021 Aug 16, 2021	SELL	$121.62 - $145.29 $5.12 Million - $6.12 Million	-42,100 Reduced 83.04%	8,600 $1.13 Million
Q4 2020 Feb 12, 2021	SELL	$151.2 - $182.76 $14.3 Million - $17.2 Million	-94,300 Reduced 65.03%	50,700 $8.46 Million
Q2 2020 Aug 14, 2020	BUY	$110.87 - $156.01 $8.38 Million - $11.8 Million	75,600 Added 108.93%	145,000 $21.4 Million
Q4 2019 Jan 31, 2020	BUY	$91.45 - $139.12 $6.35 Million - $9.65 Million	69,400 New	69,400 $9.66 Million

234

58.9M

208K

321K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.95B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.